RESUMO
Aim To investigate the effect of digoxin combined with tamoxifen on proliferation, migration, invasion of breast cancer MCF-7 cells and the possible underlying mechanism. Methods MTT, colony formation and flow cytometry were used to detect the effect of the combination therapy of tamoxifen and digoxin on proliferation and apoptosis in MCF-7 cells. Wound healing assay and transwell assay were used to detect the effect of the combination therapy of tamoxifen and digoxin on migration and invasion of MCF-7 cells. Western blot was used to detect the effect of the combination therapy of tamoxifen and digoxin on the expression of related proteins in MCF-7 cells. Results MTT, colony formation assay and flow cytometry results showed that digoxin and tamoxifen synergistically inhibited the proliferation and promoted the apoptosis of MCF-7 cells. Wound healing and transwell assay results showed that digoxin and tamoxifen synergistically inhibited the migration and invasion of MCF-7 cells. Western blot results showed that digoxin and tamoxifen synergistically inhibited the expression of PI3K, p-PI3K, p-AKT, Bcl-2, N-cadherin, Vimentin and promoted the expression of Bax, cleaved-caspase-3, cleaved-caspase-9, E-cadherin of MCF-7 cells. Conclusions Digoxin combined with tamoxifen can synergistically inhibit the proliferation, migration, invasion and induce apoptosis of MCF-7 cells, the possible mechanism of which may involve the suppression of PI3K-Akt signaling pathway and epithelial-mesenchy-mal transition (EMT).
RESUMO
Combination chemotherapy and nanoparticle drug delivery are two promising strategies in cancer treatment. The use of multiple therapeutic agents in combination provides synergistic effects among different drugs against cancer cells and suppresses drug resistance through distinct mechanisms of action.Nanocarriers can improve anti-tumor effects of drugs and reduce systemic toxicity through delivering drugs into the tumor tissue specially. Recently, many studies are aiming to encapsulate multiple agents into nanocarriers to optimize the anti-tumor effects. In the present review, the recent advances of nanoparticle platforms applied with co-delivering two or more drugs were summarized and the various combination strategies based on nanoparticles in oncology were discussed.
RESUMO
Objective:Chinese Herbal Compound I were determined by screening of Radix Scutellariae,Cortex Fraxini,Radix Pulsatillae and Radix Sophorae Flavescentis.The optimal dose of Trimethoprim which combined with it against bacteria in vitro were determined.Method:The composing prescriptions were designed by L9(34) orthogonal test.The antibacterial effect of Staphylococcus aureus,Escherichia Coli and Salmonella in vitro were evaluated by double dilution method.The number of Staphylococcus aureus,Escherichia Coli and Salmonella which had been inhabited by Chinese Herbal Compound I combined with Trimethoprim for 1,2,4h and 8h,were enumerated by Plate Counts Methods.Then the killing rate of Chinese Herbal Compound I combined with Trimethoprim were calculated.The experimental data were fitted by least squares method and the optimal dose of Trimethoprim were determined.Result:The Composition of Chinese Herbal Compound I were mixed in the proportion of 1 to 4 to 1 to 2 with Radix Scutellariae,Cortex Fraxini,Radix Pulsatillae and Radix Sophorae Flavescentis.The optimal dose of Trimethoprim was 2mg/g.Conclusion:Antibacterial action and synergistic action of Chinese Herbal Compound I were significant.
RESUMO
AIM: To study the interaction effects of Astragalus polysaccharide(APS) and total glucosides of paeony(TGP) with various dosage on the platelet aggregation. METHODS: Platelet aggregation was estimated by the turbidimetric method. The best interaction effects were determined by uniform design method. RESULTS: APS showed apparent anti-platelet effects and better combination with TGP,and the ratio of 121 was the best one. CONCLUSION: APS concerted with TGP inhibits platelet aggregation.
RESUMO
@#ObjectiveTo study neural protective effect of combined medication with nimodipine and mannitol on injury of cerebral ischemia-reperfusion for screening the better medication method in acute cerebral ischemia-reperfusion. MethodsA model of cerebral ischemia-reperfusion was performed by clipping bilateral common carotid artery of rats with vago- and releasing them 3 hours later. 40 Wistar female rats within 1 month were divided into 5 groups randomly with 8 rats each: model group (no use of medicine), nimodipine group(0.2mg/kg), mannitol group(0.5g/kg), nimodipine and mannitol group, sham-operated group (no use of medicine and no clipping process). The changes of SOD and MDA in brain tissue were measured 24 hours after cerebral ischmic reperfusion in all groups. At the same time pathologic study was performed to compare the different groups.ResultsThere were significant differences between nimodipine and mannitol group and other groups in changes of SOD, MDA and pathological changes(P<0.01). Conclusions Combined medication with nimodipine and mannitol is the better way to protect brain tissue from acute cerebral ischemia-reperfusion than other way in present experiment, by synergistic action.
RESUMO
@# ObjectiveTo study protective effect of combined medication with nimodipine and mannitol on injury of cerebral ischemia-reperfusion.MethodsA model of cerebral ischemia-reperfusion injury was performed by clipping bilateral common carotid arteries and vagi, then by releasing them to reperfuse blood into ischmic brain of rats. Changes of SOD, MDA and excitatory amino acids( glutamic acid, Glu) in serum were detected after cerebral ischmia-repefusion in different groups. At the same time pathologic study was performed. ResultsTreatment with nimodipine and mannitol is significantly effective than single medication. ConclusionsCombined medication with nimodipine and mannitol protects brain tissue from cerebral ischemia-reperfusion by synergistic action.